TY - BOOK ID - 14202206 TI - Hepatocellular carcinoma : targeted therapy and multidisciplinary care AU - McMasters, Kelly M. AU - Vauthey, Jean-Nicolas. PY - 2010 SN - 1603275215 9786612972010 1603275223 1282972014 PB - New York : Springer, DB - UniCat KW - Carcinoma, Hepatocellular -- Diagnosis. KW - Carcinoma, Hepatocellular -- therapy. KW - Liver -- Cancer -- Diagnosis. KW - Liver -- Cancer -- Treatment. KW - Liver -- Cancer. KW - Liver Neoplasms. KW - Liver Neoplasms KW - Adenocarcinoma KW - Carcinoma KW - Digestive System Neoplasms KW - Liver Diseases KW - Neoplasms by Site KW - Neoplasms, Glandular and Epithelial KW - Digestive System Diseases KW - Diseases KW - Neoplasms by Histologic Type KW - Neoplasms KW - Carcinoma, Hepatocellular KW - Medicine KW - Surgery & Anesthesiology KW - Education KW - Health & Biological Sciences KW - Social Sciences KW - Oncology KW - Surgery - General and By Type KW - Education, Special Topics KW - Liver KW - Cancer KW - Oncologic surgery KW - Oncological surgery KW - Surgical oncology KW - Treatment. KW - Surgery. KW - Chemotherapy. KW - Excision KW - Medicine. KW - Interventional radiology. KW - Gastroenterology. KW - Oncology. KW - Pathology. KW - Surgical oncology. KW - Medicine & Public Health. KW - Surgical Oncology. KW - Interventional Radiology. KW - Treatment UR - https://www.unicat.be/uniCat?func=search&query=sysid:14202206 AB - Hepatocellular Carcinoma: Targeted Therapy provides a detailed repository of the latest information regarding HCC epidemiology, diagnosis, imaging, pathology, staging, and treatment options. This volume also provides an up-to-date guide for treatment that explores not only traditional treatments, but newer investigational treatment options including surgical resection, liver transplantation, ablation (radiofrequency, microwave), percutaneous ethanol or acetic acid injection, transarterial chemoembolization (TACE), intra-arterial radiation therapy, and systemic chemotherapy. Heptocellular Carcinoma: Targeted Therapy will be of great value to all health care professionals and trainees worldwide who have an interest in the diagnosis and treatment of HCC, including surgeons, medical oncologists, radiologists, radiation oncologists, and pathologists. ER -